Spasticity - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 01-Nov-2017
No. of pages: 70
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Spasticity - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Spasticity for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Spasticity . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Spasticity for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Spasticity market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Spasticity , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Spasticity for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Spasticity 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Spasticity market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Spasticity covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Spasticity .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Spasticity .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Spasticity market trends.

  • Thorough market distribution based on market share for Spasticity .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Spasticity market.

  • To understand the future market competition in the Spasticity market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Spasticity in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Spasticity - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Spasticity Market Overview at a Glance
2.1. Total Market Share Distribution of Spasticity for 7 MM in 2016
2.2. Total Market Share Distribution of Spasticity for 7 MM in 2025

3. Spasticity
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Spasticity in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Spasticity in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Spasticity in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Spasticity in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Spasticity in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Spasticity in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Spasticity
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Spasticity Market (2016 & 2025)

9. Spasticity : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Spasticity in United States (2015-2025)
Table 2: Diagnosed Cases Spasticity in Germany (2015-2025)
Table 3: Diagnosed Cases Spasticity in France (2015-2025)
Table 4: Diagnosed Cases Spasticity in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Spasticity in Spain (2015-2025)
Table 6: Diagnosed Cases Spasticity in Italy (2015-2025)
Table 7: Diagnosed Cases Spasticity in Japan (2015-2025)
Table 8: List of Marketed Drugs for Spasticity
Table 9: List of Pipeline Phase III Drugs for Spasticity
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Spasticity in USD, Million (2015-2025)
Table 17: Germany Market Size of Spasticity in USD, Million (2015-2025)
Table 18: France Market Size of Spasticity in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Spasticity in USD, Million (2015-2025)
Table 20: Spain Market Size of Spasticity in USD, Million (2015-2025)
Table 21: Italy Market Size of Spasticity in USD, Million (2015-2025)
Table 22: Japan Market Size of Spasticity in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Spasticity in United States (2015-2025)
Figure 2: Diagnosed Cases Spasticity in Germany (2015-2025)
Figure 3: Diagnosed Cases Spasticity in France (2015-2025)
Figure 4: Diagnosed Cases Spasticity in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Spasticity in Spain (2015-2025)
Figure 6: Diagnosed Cases Spasticity in Italy (2015-2025)
Figure 7: Diagnosed Cases Spasticity in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Spasticity
Figure 9: List of Pipeline Phase III Drugs for Spasticity
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Spasticity in USD, Million (2015-2025)
Figure 17: Germany Market Size of Spasticity in USD, Million (2015-2025)
Figure 18: France Market Size of Spasticity in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Spasticity in USD, Million (2015-2025)
Figure 20: Spain Market Size of Spasticity in USD, Million (2015-2025)
Figure 21: Italy Market Size of Spasticity in USD, Million (2015-2025)
Figure 22: Japan Market Size of Spasticity in USD, Million (2015-2025)
  • Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 39
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple System Atrophy - Pipeline Review, H2 2017, provides an overview of the Multiple System Atrophy (Central Nervous System) pipeline landscape. Multiple system atrophy (MSA) or Shy-Drager syndrome is a neurological disorder that impairs body's involuntary functions (blood pressure, heart rate, bladder function and digestion). Symptoms include rigid muscles, bradykinesia, Tremors, dysarthria, d......
  • Progressive Supranuclear Palsy - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 80
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclear Palsy - Pipeline Review, H2 2017, provides an overview of the Progressive Supranuclear Palsy (Central Nervous System) pipeline landscape. Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing. Symptoms include fatigue, headaches, dizz......
  • Neuropathic Pain - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 488
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H2 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many......
  • Smoking Addiction - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 89
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smoking Addiction - Pipeline Review, H2 2017, provides an overview of the Smoking Addiction (Central Nervous System) pipeline landscape. Smoking is addictive, people experience an uncontrollable dependence on cigarettes, which on stopping will cause severe mental, emotional or physical reactions. People addicted to smoking develop tolerance to nicotine. Nicotine acts on acetylcholine receptors caus......
  • Global and United States Alcohol Addiction Therapeutics In-Depth Research Report 2017-2022
    Published: 26-Dec-2017        Price: US 3190 Onwards        Pages: 110
    The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Alcohol Addiction Therapeutics industry. Major Companies - AstraZeneca Plc - BioCorRx Inc......
  • Global Alcohol Addiction Therapeutics Sales Market Report 2018
    Published: 25-Dec-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the global Alcohol Addiction Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Alcohol Addiction Therapeutics for these regions, from 2012 to 2022 (forecast), covering - United States - China ......
  • 2015-2023 World Gabapentin Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 19-Dec-2017        Price: US 2800 Onwards        Pages: 136
    Summary Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. M......
  • Encephalopathy - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2000 Onwards        Pages: 58
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Pipeline Review, H2 2017, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape. Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, involuntary twitching and muscle weakness. Causes include traumas......
  • Canavan Disease - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2000 Onwards        Pages: 27
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Pipeline Review, H2 2017, provides an overview of the Canavan Disease (Central Nervous System) pipeline landscape. Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutation in the gene which directs the production of the enzyme asparto......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs